ClinicalTrials.gg
Not yet recruitingNCT06731634Updated Dec 12, 2024

De Quervain Syndrome Among Medical Students with Smart Phone Addiction

An observational study in De Quervain Tenosynovitis and Smartphone Addiction, sponsored by Cairo University. Not yet recruiting. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
103
Ages
18 Years to 25 Years
Sex
All
01

Study summary

To investigate the prevelance of the de quervain tenosynovitis among the Egyptian medical students with smartphone addiction

Read the detailed description

Addictive participants will be assigned and enrolled in the study according to there addiction score on smartphone addiction scale.

Participants will receive a Finkelstein test for both dominant and non dominant hand for the de quervain tenosynovitis.

Then the strentgh of both hand grip and pinch grip for both hands will be tested using hand grip strength dynamometer and pinch strentgh dynamometer.

02

Conditions studied

  • De Quervain Tenosynovitis
  • Smartphone Addiction

Keywords

  • De quervain tenosynovitis
  • Egyptian medical students
  • Cairo University
  • Smartphone addiction
  • Prevelance
03

In context

De Quervain Disease

30 studies on the registry are indexed under De Quervain Disease; 7 are open to participants now.

Browse De Quervain Disease studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,457 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population will be recruited from the medical collages of Cairo University in Egypt

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Asymptomatic students with normal healthy state
  • Any student in all the academic years with age 18-25
  • Addictive smart phone users with score over 31 for male and 33 for female students in smart phone addiction scale.
  • Who own or use mobile.
  • Both genders: male and female
  • Willing to participate.
  • Egyptian students

Exclusion criteria

Exclusion Criteria:

  • Those who don't have mobile phone.
  • Any previous injury or trauma or surgery and a history of rheumatoid arthritis, osteoarthritis, and deformities and changes in the shape of the finger joints.
  • Those who are not willing to participate.
  • Non-Egyptian students.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
103 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • One group will be assigned

    The group will include people with smartphone addiction, who will receive a Finkelstein test for both dominant and non dominant hand, then the both hands grip and bench strength will be tested.

    Device: Hand grip strength dynamometer, pinch strength dynamometer · Diagnostic Test: Finkelstein test

Interventions

  • DeviceHand grip strength dynamometer, pinch strength dynamometer

    Both devices will be used to assign the strength of grip and pinch for both dominant and non dominant hands by using jamar hydraulic hand grip strength dynamometer and Jamar hydraulic pinch strength dynamometer

  • Diagnostic testFinkelstein test

    Finkelstein test which is used to diagnose the de quervain tenosynovitis and it will be used to assist the people with smartphone addiction

06

What researchers measure

Primary outcomes

  1. Dominant hand grip strength and Non-Dominant hand grip strength by the using of jamar hydraulic grip strength dynamometer

    Time frame: 1 Day

  2. Dominant hand pinch strength and non-dominant hand pinch strength by the using of jamar hydraulic pinch strength dynamometer

    Time frame: 1 Day

Secondary outcomes

  1. The degree of pain during the finkelstein test by the using of visual analoug scale

    The visual analoug scale (vas) will be used to identify the degree of pain that the participant felt during the finkelstein test the scale values are from 0mm to 100mm 0mm means he didn't feel any pain which is good, 100mm means he felt the morst pain which is bad

    Time frame: 1 Day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2024; primary completion for Jan 2025, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2024
First posted
Dec 12, 2024
StartEst.
Dec 2024
Primary completionEst.
Jan 2025
CompletionEst.
Mar 2025
Last update
Dec 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06731634
Lead sponsor
Cairo University
Responsible party
Basil Aly Zaky Aly Amer (Physiotherapist at the egyption ministry of health, Cairo University) — Principal investigator
First posted
Dec 12, 2024
Start date
Dec 2024 (estimated)
Primary completion
Jan 2025 (estimated)
Completion
Mar 2025 (estimated)
Last update
Dec 12, 2024

Study contacts

Maher Ahmed ElKeblawy, PhD of physical therapy
Contact
maherkabalawy@gmail.com
+0201001419544

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion